Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2 Glanbia plc | Quarter 3 2021 presentation Important notice This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The Directors undertake no obligation to update any forward-looking statements contained in this presentation, whether as a result of new information, future events, or otherwise.
3 Glanbia plc | Quarter 3 2021 presentation Q3 2021 Results summary Glanbia delivers strong Q3 YTD; wholly-owned revenue +15.7% cc GPN LFL Branded revenue +25.2% cc GN Nutritional Solutions volume +15.7% cc Strong cash conversion, net debt reduced by €39 million to €589 million Announcing proposed sale of PLC’s 40% shareholding in Glanbia Ireland to Glanbia Co-op for €307 million “cc” denotes constant currency
4 Glanbia plc | Quarter 3 2021 presentation 2021 Strategic update and outlook On schedule for targeted results Acquired PacMoore, in NS, for $52 million Maintain supply chain delivery Delivering revenue growth and efficiencies Completed second share buyback Manage cost inflation returning €100 million in past 12 months 2021 Adjusted EPS, constant currency, growth expected to be at the upper end of the 17% to 22% range Maintain our strong financial position
5 Glanbia plc | Quarter 3 2021 presentation Proposed sale of PLC stake in Glanbia Ireland Description Strategic rationale Transaction details Glanbia has signed a memorandum of Enables both shareholders to focus Selling price €307 million understanding with Glanbia Co-op to on their respective strategic agendas Transaction subject to agreement sell its 40% shareholding in Glanbia of binding legal contracts Ireland Proceeds will be deployed on growth and shareholder returns Glanbia Ireland is 60% owned by PLC will focus on driving sustainable Transaction subject to shareholder Glanbia Co-op and 40% by the PLC growth in nutrition through its two approvals. Expected completion growth platforms of GPN and GN H1 2022
7 Glanbia plc | Quarter 3 2021 presentation GPN Q3 YTD 2021 update +25.2% Q3 YTD 2021 Revenue Progression, cc 25% 0.8% Americas 20% 4.4% • Strong performance driven by Optimum Nutrition • Price increase implemented during Q3 15% • Ongoing headwinds in Diet category International • ASPAC and Middle East very strong performance 10% 18.0% • European markets and DTC performing well • GPN Transformation has facilitated revenue growth management, route-to-market optimisation and brand focus 5% during the year 0% Volume Price Acquisition “cc” denotes constant currency
8 Glanbia plc | Quarter 3 2021 presentation Leading brands positioned for growth Brand health Brand health • 12 week consumption to 3 October 2021 in NA • 12 week consumption to 3 October 2021 in NA measured measured channels* +18.6% channels* -8.8% Category update Category update • Strong performance across all channels • Covid headwinds in Diet category • Expanding into new consumer occasions • Focused on brand activation and innovation *North America measured channels include Online, FDMC (Food, Drug, Mass, Club) and Specialty channels. Date provided is for L12 weeks to 3 October 2021
10 Glanbia plc | Quarter 3 2021 presentation Glanbia Nutritionals Q3 2021 update Q3 2021 Revenue Progression, cc 20% 16% Volume (6.6%) • Strong customer demand across all business segments 12% 1.0% Price • Price related to lower year-on-year cheese markets 18.2% 8% Acquisition 4% • ‘PacMoore’ is a US food manufacturer specialising in protein applications, including texturisation • The acquisition will enhance NS’s growth in the 0% healthy snacking solutions category Volume Price Acquisition • Purchase price of $52 million “cc” denotes constant currency
11 Glanbia plc | Quarter 3 2021 presentation Nutritional Solutions Q3 2021 update +15.7% Q3 2021 Revenue Progression, cc 20% 3.3% Volume 1.9% • Strong volume performance in micro-nutrients and 15% healthy snacking solutions • Consumer trends accelerating demand Price 10% • Driven by healthy snacking solutions • Strong demand for underlying dairy ingredients 15.7% Acquisitions 5% • Foodarom and PacMoore performing well 0% Volume Price Acquisition “cc” denotes constant currency
12 Glanbia plc | Quarter 3 2021 presentation US Cheese Q3 2021 update Q3 2021 Revenue Progression, cc 20% Volume • Q3 volumes driven by new Joint Venture capacity fully 16% commissioned during the year (10.1%) 12% Price • Price decline driven by lower cheese markets 19.3% 8% 4% 0% Volume Price “cc” denotes constant currency
Finance Q3 2021 review
14 Glanbia plc | Quarter 3 2021 presentation Strong Cash Flow and Balance Sheet Q3 2021 Q3 2020 Cash Net Debt €589m €628m generative Net debt: Adjusted 1.50X 1.95X EBITDA • Rolling 12 months operating cash flow well ahead of 80% target Facilitating Balance • Strong balance sheet facilitates investment capability investment Sheet capacity • At Q3 2021 - Total committed facilities of €1.1 billion with earliest maturity January 2024
15 Glanbia plc | Quarter 3 2021 presentation Capital Allocation Expect to invest in FY 21 Invested €84 million In last 12 months Policy
Conclusion
17 Glanbia plc | Quarter 3 2021 presentation Conclusions Good revenue momentum in Q3 2021 with trends continuing into Q4 Strategic initiatives on track and navigating inflation through pricing and efficiencies Strong balance sheet to fund growth Positive outlook; in FY 21 Adjusted EPS growth, constant currency, expected to be at the upper end of the 17% to 22% range
Questions
You can also read